{"id":"tp-50304","type":"article-newspaper","title":"Intellia Therapeutics Revenue Misses Estimates as GAAP Loss Per Share Hits $0.91","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50304","datePublished":"2026-11-06T19:35:20.000Z","dateModified":"2026-11-06T19:35:20.000Z","language":"en","abstract":"Total revenue was $7.16 million, $2.61 million below estimates. Collaboration revenue fell 48% year over year to $7.2 million.","section":"Business","references":[]}